Aurinia Pharmaceuticals Inc.
AUPH
$14.07
-$0.01-0.07%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 14,651.15% | 119.87% | 2,879.64% | 317.17% | 105.32% |
| Total Depreciation and Amortization | 0.04% | -0.57% | 0.43% | 0.19% | -1.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -13,241.18% | -55.76% | 136.08% | 0.36% | -92.01% |
| Change in Net Operating Assets | -71.10% | 134.77% | 11.49% | -132.06% | 15.69% |
| Cash from Operations | 51.65% | 161.02% | 179.25% | 106.99% | 110.41% |
| Capital Expenditure | 74.38% | -146.43% | 23.44% | -41.67% | 6.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -192.86% | -27.96% | 65.77% | -36.95% | 763.04% |
| Cash from Investing | -193.71% | -30.27% | 65.63% | -36.97% | 726.87% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -15.08% | -16.57% | -6.42% | 0.25% | 53.69% |
| Issuance of Common Stock | -3.35% | 394.54% | 29.70% | 68.14% | -37.44% |
| Repurchase of Common Stock | 98.35% | -5,310.18% | -570.55% | -213.84% | -867.35% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 91.80% | -285.38% | -436.61% | -227.80% | -313.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -84.83% | 440.48% | 56.76% | -209.12% | 1,768.08% |